Characteristic transformation of blood transcriptome in Alzheimer's disease.

Blood transcriptome has emerged as a potential resource for the discovery of biomarkers for Alzheimer's disease (AD). However, the validity of blood transcriptome in the early diagnosis of AD has yet to be extensively tested. In this work, we analyzed published data on AD blood transcriptome and revealed the characteristic perturbation of cellular functional units, including upregulation of environmental responses (immune response, survival/death signaling, and cellular recycling) and down-regulation of core metabolism (energy metabolism and translation/splicing). This characteristic perturbation was unique to AD based on the comparison with blood transcriptome from other neurological disorders and complex diseases. More importantly, similar perturbation was observed in both AD and mild cognitive impairment (MCI) groups. This perturbation pattern was further validated in our independent microarray experiment in a small Chinese cohort. In addition, the potential effect of aging and lifestyle on blood transcriptome was discussed. Based on the analyses, we propose that the transformation of the blood transcriptome in AD is an integrated part of the disease mechanism and has potential to serve as a reliable biomarker for assisting the early diagnosis as well as monitoring purpose. Therefore, more independent studies on blood transcriptome of AD and MCI with larger sample size are warranted.

[1]  M. Sade-Feldman,et al.  New insights into chronic inflammation-induced immunosuppression. , 2012, Seminars in cancer biology.

[2]  Guanghua Xiao,et al.  A serum protein-based algorithm for the detection of Alzheimer disease. , 2010, Archives of neurology.

[3]  Hongxing Lei,et al.  Down-regulation of energy metabolism in Alzheimer's disease is a protective response of neurons to the microenvironment. , 2012, Journal of Alzheimer's disease : JAD.

[4]  C. Jack,et al.  Evidence for ordering of Alzheimer disease biomarkers. , 2011, Archives of neurology.

[5]  Virginia Pascual,et al.  A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. , 2008, Immunity.

[6]  Yong Duan,et al.  iBIG: An Integrative Network Tool for Supporting Human Disease Mechanism Studies , 2013, Genom. Proteom. Bioinform..

[7]  Masao Honda,et al.  Identification of blood biomarkers of aging by transcript profiling of whole blood. , 2012, Biochemical and biophysical research communications.

[8]  C. Caltagirone,et al.  Dysregulated NF-κB pathway in peripheral mononuclear cells of Alzheimer's disease patients. , 2012, Current Alzheimer research.

[9]  Lukasz Itert,et al.  Subtype-specific Peripheral Blood Gene Expression Profiles in Recent Onset Juvenile Idiopathic Arthritis Nih Public Access Author Manuscript Subjects, Materials and Metods Subjects and Controls Labeling Rna Quality Was Assessed Using an Agilent 2100 Bioanalyzer According to Standard Protocols in the , 2022 .

[10]  Rainer Breitling,et al.  RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis , 2006, Bioinform..

[11]  S. Bandinelli,et al.  Human aging is characterized by focused changes in gene expression and deregulation of alternative splicing , 2011, Aging cell.

[12]  J. Jia,et al.  Mitochondrial fission proteins in peripheral blood lymphocytes are potential biomarkers for Alzheimer’s disease , 2012, European journal of neurology.

[13]  D. Aarsland,et al.  A novel blood test for the early detection of Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[14]  José M Ferro,et al.  TTC7B Emerges as a Novel Risk Factor for Ischemic Stroke Through the Convergence of Several Genome-Wide Approaches , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[15]  Dietrich A. Stephan,et al.  Autism and Increased Paternal Age Related Changes in Global Levels of Gene Expression Regulation , 2011, PloS one.

[16]  J. Growdon,et al.  Molecular markers of early Parkinson's disease based on gene expression in blood , 2007, Proceedings of the National Academy of Sciences.

[17]  Nan Hu,et al.  A Gene Expression Signature from Peripheral Whole Blood for Stage I Lung Adenocarcinoma , 2011, Cancer Prevention Research.

[18]  Pan Du,et al.  lumi: a pipeline for processing Illumina microarray , 2008, Bioinform..

[19]  Peripheral Mitochondrial Dysfunction in Alzheimer’s Disease: Focus on Lymphocytes , 2012, Molecular Neurobiology.

[20]  J. Gregg,et al.  Gene expression changes in children with autism. , 2008, Genomics.

[21]  Hyman M. Schipper,et al.  Transcriptional profiling of Alzheimer blood mononuclear cells by microarray , 2007, Neurobiology of Aging.

[22]  Wu Hong,et al.  Blood-Based Gene Expression Profiles Models for Classification of Subsyndromal Symptomatic Depression and Major Depressive Disorder , 2012, PloS one.

[23]  Mauro Delorenzi,et al.  Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood , 2007, Proceedings of the National Academy of Sciences.

[24]  E. Huang,et al.  Integrating Factor Analysis and a Transgenic Mouse Model to Reveal a Peripheral Blood Predictor of Breast Tumors , 2011, BMC Medical Genomics.

[25]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[26]  F. Zitman,et al.  Stimulated Gene Expression Profiles as a Blood Marker of Major Depressive Disorder , 2010, Biological Psychiatry.

[27]  Hongxing Lei,et al.  Amyloid and Alzheimer’s disease , 2010, Protein & Cell.

[28]  Solve Sæbø,et al.  A gene expression pattern in blood for the early detection of Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[29]  R. Fisher.  On the Interpretation of χ2 from Contingency Tables, and the Calculation of P , 2018, Journal of the Royal Statistical Society Series A (Statistics in Society).

[30]  Zina M. Ibrahim,et al.  Mitochondrial dysfunction and immune activation are detectable in early Alzheimer's disease blood. , 2012, Journal of Alzheimer's disease : JAD.

[31]  M. Brown,et al.  Whole blood transcriptional profiling in ankylosing spondylitis identifies novel candidate genes that might contribute to the inflammatory and tissue-destructive disease aspects , 2011, Arthritis Research & Therapy.

[32]  How to get from here to there: macrophage recruitment in Alzheimer's disease. , 2011, Current Alzheimer research.

[33]  Mark E. Schmidt,et al.  The Alzheimer’s Disease Neuroimaging Initiative: A review of papers published since its inception , 2012, Alzheimer's & Dementia.

[34]  M. Brown,et al.  The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis. , 2010, Human molecular genetics.

[35]  Y. Benjamini,et al.  Controlling the false discovery rate in behavior genetics research , 2001, Behavioural Brain Research.

[36]  C. Kruse,et al.  Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease. , 2010, Brain : a journal of neurology.

[37]  E. Streck,et al.  Evaluation of respiratory chain activity in lymphocytes of patients with Alzheimer disease , 2011, Metabolic Brain Disease.

[38]  O. Maes,et al.  Methodology for discovery of Alzheimer's disease blood-based biomarkers. , 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.

[39]  P. Bertolucci,et al.  Apolipoprotein E4 allele and ribosomal genes in Alzheimer's disease. , 2004, Journal of Alzheimer's disease : JAD.

[40]  Amy L. Shelton,et al.  Reduction of Hippocampal Hyperactivity Improves Cognition in Amnestic Mild Cognitive Impairment , 2012, Neuron.

[41]  Monique E. Beaudoin,et al.  Regulating amyloid precursor protein synthesis through an internal ribosomal entry site , 2008, Nucleic acids research.

[42]  J. Kaprio,et al.  Systematic review of genome-wide expression studies in multiple sclerosis , 2011, BMJ Open.

[43]  Chih-ping Chen,et al.  Management of moderate to severe Alzheimer's disease: focus on memantine. , 2011, Taiwanese journal of obstetrics & gynecology.

[44]  Robert J Freishtat,et al.  BMC Medicine BioMed Central , 2009 .

[45]  Zsolt Tulassay,et al.  Diagnostic mRNA Expression Patterns of Inflamed, Benign, and Malignant Colorectal Biopsy Specimen and their Correlation with Peripheral Blood Results , 2008, Cancer Epidemiology Biomarkers & Prevention.

[46]  J. Li,et al.  Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease , 2011, Neurology.

[47]  Dominique Drouin,et al.  Toward an Alzheimer's disease diagnosis via high-resolution blood gene expression , 2010, Alzheimer's & Dementia.

[48]  Pei Wang,et al.  Gene expression profiling of peripheral blood leukocytes identifies and validates ABCB1 as a novel biomarker for Alzheimer's disease , 2011, Neurobiology of Disease.

[49]  René S. Kahn,et al.  A Gene Co-Expression Network in Whole Blood of Schizophrenia Patients Is Independent of Antipsychotic-Use and Enriched for Brain-Expressed Genes , 2012, PloS one.

[50]  Dapeng Liang,et al.  Concerted Perturbation Observed in a Hub Network in Alzheimer’s Disease , 2012, PloS one.

[51]  R V Jensen,et al.  Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[52]  Yoko Kamio,et al.  Autism-Associated Gene Expression in Peripheral Leucocytes Commonly Observed between Subjects with Autism and Healthy Women Having Autistic Children , 2011, PloS one.

[53]  S. Black,et al.  National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards , 2006, Stroke.

[54]  P. Bosco,et al.  Genome-wide gene expression profiling of human narcolepsy. , 2012, Gene expression.